Senior Executives From Samsara, Luma Health, and Gusto Join Assort Health Following $222M in Funding

Assort Health has successfully completed a $120 million Series C funding round, significantly bolstering its resources to expand its leadership team and scale its operations in response to increasing demand. This funding round, led by Menlo Ventures, brings the total capital raised by the company to $222 million. The announcement was made on July 21, 2026, coinciding with the company's strategic hiring of three senior executives to enhance its capabilities in the rapidly evolving healthcare technology sector.

The newly appointed executives include Jon Corn as Chief Revenue Officer, Kristina Kemp as Vice President of Customer Success, and Emil Yeargin as Senior Vice President of People. These hires are part of Assort Health's strategy to transition from AI pilots to comprehensive enterprise solutions that streamline patient access across various healthcare processes. The company has experienced remarkable growth, with revenue increasing twentyfold over the past 15 months, positioning itself as a leader in the AI agents platform for the patient journey.

Assort Health's platform is distinguished by its extensive dataset, which encompasses over 200 million patient interactions and 62,000 care protocols. This robust foundation enables the company to offer tailored solutions that address the complexities of healthcare, ranging from scheduling and intake to medication refills and payments. The strategic focus on building a cohesive leadership team is aimed at enhancing the company's ability to serve large health systems and provider groups that are increasingly seeking reliable, integrated AI solutions.

The appointment of Jon Corn, who previously excelled at Samsara, is particularly notable as he brings a wealth of experience in scaling go-to-market strategies for complex customer relationships. His leadership is expected to drive Assort Health's growth in enterprise accounts, while Kristina Kemp's background in customer success will enhance client engagement and satisfaction. Emil Yeargin's expertise in organizational development will be critical as the company continues to expand its workforce and operational capabilities.

The broader implications of this funding and leadership expansion reflect a growing trend in the healthcare sector, where organizations are moving toward integrated AI platforms to improve operational efficiency and patient outcomes. As healthcare providers increasingly standardize on comprehensive solutions, Assort Health is well-positioned to capitalize on this shift, leveraging its extensive dataset and innovative technology to meet the evolving needs of the industry.

Looking ahead, Assort Health plans to further expand its teams across engineering, operations, customer success, and go-to-market functions throughout 2026. This strategic growth initiative underscores the company's commitment to enhancing its platform and maintaining its competitive edge in the healthcare technology landscape. As the demand for sophisticated AI solutions continues to rise, Assort Health's proactive approach to leadership and innovation may set a benchmark for success in the sector.